Next Article in Journal
Anti-Leukemic Properties of Aplysinopsin Derivative EE-84 Alone and Combined to BH3 Mimetic A-1210477
Previous Article in Journal
Model-Free Approach for the Configurational Analysis of Marine Natural Products
Previous Article in Special Issue
Fucoidans of Moroccan Brown Seaweed as Elicitors of Natural Defenses in Date Palm Roots
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Fucoidans as Scientifically and Commercially Important Algal Polysaccharides

by
K. K. Asanka Sanjeewa
and
You-Jin Jeon
*
Department of Marine Life Science, Jeju National University, Jeju 690-756, Korea
*
Author to whom correspondence should be addressed.
Mar. Drugs 2021, 19(6), 284; https://doi.org/10.3390/md19060284
Submission received: 14 May 2021 / Accepted: 18 May 2021 / Published: 21 May 2021
(This article belongs to the Special Issue Fucoidans)

1. Introduction

As a highly bioactive seaweed substance with many promising physiological activities, fucoidan has attracted attention from many industries all over the world. Even though fucoidans are a rich source of bioactive properties, the structural properties and bioactive mechanisms of fucoidans are poorly understood. Therefore, novel studies that either characterize the physical properties or biological activities of fucoidans will fill the knowledge gap between industrial applications and the scientific background of those applications.
Both purified and partially purified fucoidans isolated from brown seaweeds present high potential as preventative and therapeutic agents against a number of chronic diseases due to their anti-inflammatory, antioxidant, anticancer, neuroprotective, antiviral, antimicrobial, and anticoagulative properties.
This Special Issue is aimed at presenting updated information on well-documented studies of the structural characterization and major biological actions relevant for medical, cosmeceutical, and pharmaceutical applications that fucoidans isolated from brown seaweed can offer.

2. What Is Fucoidan

Fucoidan is a type of sulfated polysaccharide which contains a significant portion of L-fucose. Fucoidans are mainly extracted from brown seaweeds and one of the well-known bio-active polysaccharides collected from seaweeds [1]. Earlier Fucoidan was named as “fucoidin” when it was first separated from seaweeds by Kylin in 1913. According to the IUPAC rules correct term is fucoidan. However, some people still use fucosan, fucan, and sulfated fucan instead of fucoidan [2]. In recent years, fucoidan has been extensively studied due to its beneficial and interesting biological activities [3]. Specifically, fucoidan possess numerous bioactive properties such as, anti-inflammatory, immunomodulatory, antioxidant, anticoagulant, antivirus, anticancer, and gastric protective properties.

3. The Structure Characterization

With the effort of the scientific community, several fucoidans’ structures have been elucidated, and their biological activities have been identified [3]. The structure of fucoidans is complex in nature and it is very difficult to elucidate the general structure due to their heterogenous nature [4]. However, the majority of algal fucoidans consist of a linear backbone of random 1 → 3 or 1 → 4 linked α-L-fucopyranose residues periodically interrupted by other monosaccharides. Sulfate ester groups are arbitrarily substituted at 2, 3 and/or 4 positions of fucopyranose units, making it a highly heterogenous polymer [1,5].

4. How to Prepare

Fucoidan contents of brown seaweeds depend on a lot of factors such as variety, harvesting season, and maturity stage of seaweeds. In general, polysaccharides available in seaweeds can be extracted using water with or without some special enzymes, and separated by adding organic solvents [6]. However, extractions of cell wall polysaccharides are little bit difficult with the solvent extraction process. To extract cell wall polysaccharides such as fucoidan requires lyases in order to increase the extraction efficiency. Therefore, an enzyme-assisted extraction technique can be employed as an alternative method to enhance the extraction efficiency of fucoidan for industrial use [7].
In the article by Dörschmann, P. et al. [8], the authors enzymatically extracted Saccharina latissima fucoidan and isolated its low-molecular weight fraction. The results showed that the enzyme-treated fucoidans and the fractionated low-molecular-weight fucoidans are very promising for beneficial age-related macular degeneration-relevant biological activities. In order to modify fucoidans in molecular weights, fucoidans can be hydrolyzed by enzymes or phyco-chemical treatments and the resultant smaller fucoidans or fucoidan oligomers might improve bioactivities. In this Special Issue, a native fucoidan extracted from Sargassum crassifolium pretreated by single-screw extrusion was degraded by ascorbic acid or hydrogen peroxide. The lower-molecular-weight fucoidan prepared by ascorbic acid exhibits the highest cytotoxicity to A-549 cells and a strong ability to suppress Bcl-2 expression [9]. Tan, J. et al. [10] isolated fucoidan from Saccharina japonica and prepared its depolymerized fragment by oxidant degradation. The molecular weights of Fucoidan and its depolymerized fragment were 136 and 9.5 kDa, respectively. The low-molecular-weight fucoidan had higher renoprotective activity on adriamycin-induced nephrotic syndrome. On the other hand, Zayed, A. and Ulber, R. [11] mentioned in their review article that since a universal protocol for fucoidans production has not been established yet, all the currently used processes were presented and justified. The review article in the fucoidans field provided an updated overview regarding the different downstream processes, including pre-treatment, extraction, purification and enzymatic modification processes, and shows the recent non-traditional applications of fucoidans in relation to their characters.

5. Important Bioactivities

With the growing interest towards functional materials from natural sources, fucoidans isolated from different seaweeds have been scientifically and industrially studied aiming at assessing their potential biological activities such as anti-inflammatory, immunomodulatory, antioxidant, anticoagulant, antivirus, and anticancer properties [5,12]. Besides the cellular level activities, studies also focused on non-classical studies from fucoidans such as angiogenesis, treatment of intestinal diseases (inflammatory bowel disease and gastric ulcers), treatment of metabolic syndrome, and bone health supplements [13,14]. In this Special Issue, many articles provided bioactivities and physiological functionalities of fucoidans; for example, fucoidans of Moroccan brown seaweed act as an elicitor of natural defenses in date palm roots [15] and fucoidan from Ascophyllum nodosum suppresses postprandial hyperglycemia by inhibiting Na+/glucose cotransporter 1 activity [16]. It is well known that fucoidans show a protective effect against apoptosis [17] and ultraviolet B-induced photodamage [18]. On the other hand, one of the important bioactivities of fucoidans is an anticancer effect. Two articles in the Special Issue published anticancer activities of fucoidan via inducing apoptosis of cancer cells [19,20]. M. E. Reyes et al. reviewed brown seaweed fucoidan in cancer, in particular introduced implications in metastasis and drug resistance [21]. Typical bioactivities of fucoidans are antibacterial and antioxidant. Fucoidans in this Special Issue exhibited antibacterial effect against Helicobacter pylori infection [22] and antioxidant effect against oxidative stress [23]. Fucoidans can be effective on skin. Takahashi, M. et al. [24] have studied the improvement of psoriasis by alteration of the gut environment by oral administration of fucoidan. Furthermore, fucoidans were recently utilized to create a multilayer film with chitosan to bind fibroblast growth factor-2 for pharmaceutical-grade use [25].

6. Conclusions

Functional food is considered to be any food or food component that provides health benefits beyond basic nutrition. Recently, considerable attention has been directed by consumers towards functional ingredients from food, because of the lack of side effects. Compared with other polysaccharides, fucoidans are sulfated polysaccharides and are very active in their functions. In order to be commercially and widely available as functional food additives, a large number of fucoidans have been investigated in recent years.

Funding

This work was supported by the 2021 education, research and student guidance grant funded by Jeju National University.

Conflicts of Interest

The author declares no conflict of interest.

References

  1. Fernando, I.P.S.; Dias, M.; Madusanka, D.M.D.; Han, E.J.; Kim, M.J.; Jeon, Y.J.; Ahn, G. Fucoidan refined by Sargassum confusum indicate protective effects suppressing photo-oxidative stress and skin barrier perturbation in UVB-induced human keratinocytes. Int. J. Biol. Macromol. 2020, 164, 149–161. [Google Scholar] [CrossRef] [PubMed]
  2. Li, B.; Lu, F.; Wei, X.; Zhao, R. Fucoidan: Structure and bioactivity. Molecules 2008, 13, 1671–1695. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Sanjeewa, K.K.A.; Jayawardena, T.U.; Kim, S.-Y.; Kim, H.-S.; Ahn, G.; Kim, J.; Jeon, Y.-J. Fucoidan isolated from invasive Sargassum horneri inhibit LPS-induced inflammation via blocking NF-κB and MAPK pathways. Algal Res. 2019, 41, 101561. [Google Scholar] [CrossRef]
  4. Asanka Sanjeewa, K.K.; Jayawardena, T.U.; Kim, H.S.; Kim, S.Y.; Shanura Fernando, I.P.; Wang, L.; Abetunga, D.T.U.; Kim, W.S.; Lee, D.S.; Jeon, Y.J. Fucoidan isolated from Padina commersonii inhibit LPS-induced inflammation in macrophages blocking TLR/NF-kappaB signal pathway. Carbohydr. Polym. 2019, 224, 115195. [Google Scholar] [CrossRef]
  5. Ale, M.T.; Mikkelsen, J.D.; Meyer, A.S. Important determinants for fucoidan bioactivity: A critical review of structure-function relations and extraction methods for fucose-containing sulfated polysaccharides from brown seaweeds. Mar. Drugs 2011, 9, 2106–2130. [Google Scholar] [CrossRef] [Green Version]
  6. Wijesinghe, W.A.J.P.; Jeon, Y.-J. Biological activities and potential industrial applications of fucose rich sulfated polysaccharides and fucoidans isolated from brown seaweeds: A review. Carbohydr. Polym. 2012, 88, 13–20. [Google Scholar] [CrossRef]
  7. Sanjeewa, K.K.; Fernando, I.P.; Kim, E.A.; Ahn, G.; Jee, Y.; Jeon, Y.J. Anti-inflammatory activity of a sulfated polysaccharide isolated from an enzymatic digest of brown seaweed Sargassum horneri in RAW 264.7 cells. Nutr. Res. Pr. 2017, 11, 3–10. [Google Scholar] [CrossRef] [Green Version]
  8. Dörschmann, P.; Mikkelsen, M.D.; Thi, T.N.; Roider, J.; Meyer, A.S.; Klettner, A. Effect of a newly developed enzyme-assisted extraction method on the biological activities of fucoidans in ocular cells. Mar. Durgs 2020, 18, 282. [Google Scholar] [CrossRef]
  9. Wu, T.-C.; Hong, Y.-H.; Tsai, Y.-H.; Hsieh, S.-L.; Huang, R.-H.; Kuo, C.-H.; Huang, C.-Y. Degradation of Sargassum crassifolium fucoidan by ascorbic acid and hydrogen peroxide and compositional, structural, and in vitro anti-lung cancer analyses of the degradation products. Mar. Durgs 2020, 18, 334. [Google Scholar] [CrossRef]
  10. Tan, J.; Wang, J.; Geng, L.; Yue, Y.; Wu, N.; Zhang, Q. Comparative study of fucoidan from Saccharina japonica and its depolymerized fragment on Adriamycin-induced nephrotic syndrome in rats. Mar. Durgs 2020, 18, 137. [Google Scholar] [CrossRef] [Green Version]
  11. Zayer, A.; Ulber, R. Fucoidans: Downstream processes and recent applications. Mar. Durgs 2020, 18, 170. [Google Scholar]
  12. Phull, A.R.; Kim, S.J. Fucoidan as bio-functional molecule: Insights into the anti-inflammatory potential and associated molecular mechanisms. J. Funct. Foods 2017, 38, 415–426. [Google Scholar] [CrossRef]
  13. Wang, Y.; Xing, M.; Cao, Q.; Ji, A.; Liang, H.; Song, S. Biological Activities of Fucoidan and the Factors Mediating Its Therapeutic Effects: A Review of Recent Studies. Mar. Durgs 2019, 17, 183. [Google Scholar] [CrossRef] [Green Version]
  14. Vo, T.-S.; Kim, S.-K. Fucoidans as a natural bioactive ingredient for functional foods. J. Funct. Foods 2013, 5, 16–27. [Google Scholar] [CrossRef]
  15. Bouissil, S.; Alaoui-Talibi, Z.E.; Pierre, G.; Rchid, H.; Michaud, P.; Delattre, C.; Modafar, C.E. Fucoidans of Moroccan brown seaweed as elicitors of natural defenses in data palm roots. Mar. Drugs 2020, 18, 596. [Google Scholar] [CrossRef]
  16. Shan, X.; Wang, X.; Jiang, H.; Cai, C.; Hao, J.; Yu, G. Fucoidan from Ascophyllum nodosum suppresses postprandial hyperglycemia by inhibiting Na+/glucose cotransporter 1 activity. Mar. Drugs 2020, 18, 485. [Google Scholar] [CrossRef]
  17. Liu, H.; Wang, J.; Zhang, Q.; Geng, L.; Yang, Y.; Wu, N. Protective effect of fucoidan against MPP+-induced Sh-Sy5Y cells apoptosis by affecting the PI3K/Akt pathway. Mar. Drugs 2020, 18, 333. [Google Scholar] [CrossRef]
  18. Su, W.; Wang, L.; Fu, X.; Ni, L.; Duan, D.; Xu, J.; Gao, X. Protective effect of a fucose-rich fucoidan isolated from Saccharina japonica against ultraviolet B-induced photodamage in vitro in human keratinocytes and in vivo in zebrafish. Mar. Drugs 2020, 18, 316. [Google Scholar] [CrossRef]
  19. Bai, X.; Wang, Y.; Bu, B.; Cao, Q.; Xing, M.; Song, S.; Ji, A. Fucoidan induces apoptosis of HT-29 cells via the activation of DR4 and mitochondrial pathway. Mar. Drugs 2020, 18, 220. [Google Scholar] [CrossRef] [PubMed]
  20. Fernando, I.P.S.; Sanjeewa, K.K.A.; Lee, H.G.; Kim, H.-S.; Vaas, A.P.J.P.; Silva, H.I.C.D.; Nanayakkara, C.M.; Abeytonga, D.T.U.; Lee, D.-S.; Lee, J.-S.; et al. Fucoidan purified from Sargassum polycystum induces apoptosis through mitochondria-mediated pathway in HL-60 and MCF-7 cells. Mar. Drugs 2020, 18, 196. [Google Scholar] [CrossRef] [Green Version]
  21. Reyes, M.E.; Riquelme, I.; Salvo, T.; Zanella, L.; Letelier, P.; Brebi, P. Brown seaweed fucoidan in cancer: Implication in metastasis and drug resistance. Mar. Drugs 2020, 18, 232. [Google Scholar] [CrossRef] [PubMed]
  22. Tomori, M.; Nagamine, T.; Iha, M. Are Helicobacter pylori infection and fucoidan consumption associated with fucoidan absorption? Mar. Drugs 2020, 18, 235. [Google Scholar]
  23. Jayawardena, T.U.; Wang, L.; Sanjeewa, K.K.A.; Kang, S.I.; Lee, J.-S.; Jeon, Y.-J. Antioxidant potential of sulfated polysaccharides from Padina boryana; Protective effect against oxidative stress in in vitro and in vivo zebrafish model. Mar. Drugs 2020, 18, 212. [Google Scholar] [CrossRef] [Green Version]
  24. Takahashi, M.; Takahashi, K.; Abe, S.; Yamada, K.; Suzuki, M.; Masahisa, M.; Endo, M.; Abe, K.; Inoue, R.; Hoshi, H. Improvement of psoriasis by alteration of the gut environment by oral administration of fucoidan from Cladosiphon okamuranus. Mar. Drugs 2020, 18, 154. [Google Scholar] [CrossRef] [Green Version]
  25. Benbow, N.; Karpiniec, S.; Krasowska, M.; Beattie, D.A. Incorporation of FGF-2 into pharmaceutical grade fucoidan/chitosan polyelectrolyte multilayers. Mar. Drugs 2020, 18, 531. [Google Scholar] [CrossRef]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Sanjeewa, K.K.A.; Jeon, Y.-J. Fucoidans as Scientifically and Commercially Important Algal Polysaccharides. Mar. Drugs 2021, 19, 284. https://doi.org/10.3390/md19060284

AMA Style

Sanjeewa KKA, Jeon Y-J. Fucoidans as Scientifically and Commercially Important Algal Polysaccharides. Marine Drugs. 2021; 19(6):284. https://doi.org/10.3390/md19060284

Chicago/Turabian Style

Sanjeewa, K. K. Asanka, and You-Jin Jeon. 2021. "Fucoidans as Scientifically and Commercially Important Algal Polysaccharides" Marine Drugs 19, no. 6: 284. https://doi.org/10.3390/md19060284

APA Style

Sanjeewa, K. K. A., & Jeon, Y. -J. (2021). Fucoidans as Scientifically and Commercially Important Algal Polysaccharides. Marine Drugs, 19(6), 284. https://doi.org/10.3390/md19060284

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop